As of June 2022 Allogene Therapeutics has a market cap of $1.59 Billion. This makes Allogene Therapeutics the world's 3748th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2022 | $1.76 B | -17.07% |
2021 | $2.12 B | -39.95% |
2020 | $3.54 B | 11.8% |
2019 | $3.16 B | -3.19% |
2018 | $3.27 B |
On Jun 28th, 2022 the market cap of Allogene Therapeutics was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() ORIC Pharmaceuticals
ORIC | $0.18 B | -88.37% | ๐บ๐ธ USA |